清肺口服液治疗小儿病毒性肺炎痰热闭肺证507例临床研究
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

江苏省社会发展计划项目(编号:BS96052);“十五”国家科技攻关计划项目(编号:2001BA701A16b)


Clinical Study on Qingfei Oral Liquid Treating 507 Cases of Phlegm-heat Obstructing Lung Syndrome in Children Virus Pneumonia
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察清肺口服液治疗小儿病毒性肺炎痰热闭肺证的有效性、安全性。方法:以利巴韦林注射液为对照,采用清肺口服液治疗小儿病毒性肺炎痰热闭肺证,进行了两期6中心的507例随机对照临床试验。结果:两期临床研究的结果均表明:清肺口服液临床疗效显著优于利巴韦林注射液(P<0.05):清肺口服液和利巴韦林注射液均未见明显的临床不良反应。结论:清肺口服液是治疗小儿病毒性肺炎痰热闭肺证有效而安全的药物。

    Abstract:

    To study the effectiveness and safety of Qingfei Oral Liquid for phlegm-heat obstructing lung syndrome in children virus pneumonia.Methods:A total of 507 cases of phlegm-heat obstructing lung syndrome in children virus pneumonia were studied in two-stage and six-center randomized controlled clinical trials.Qingfei oral liquid was used in treat group,while ribavirin injection was used in control group.Results:Two-stage clinical trials showed that the effect of Qingfei Oral Liquid was significantly better than that of ribavirin injection(P<0.05).Conclusion:Qingfei Oral Liquid is effective and safe in treating phlegm-heat obstructing lung syndrome in children virus pneumonia.

    参考文献
    相似文献
    引证文献
引用本文

汪受传,孙轶秋,卞国本,徐玲,马融,王孟清,刘光陵.清肺口服液治疗小儿病毒性肺炎痰热闭肺证507例临床研究[J].世界中医药,2016,(09).

复制
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2016-09-09
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2016-10-17
  • 出版日期:
文章二维码